<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE SHEET AND STATEMENT OF OPERATIONS OF UROLOGIX FOR THE NINE MONTH PERIOD ENDING MARCH 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> JUN-30-2000 <PERIOD-START> JUL-01-1999 <PERIOD-END> MAR-31-2000 <CASH> 373,887 <SECURITIES> 24,222,956 <RECEIVABLES> 1,629,072 <ALLOWANCES> 220,494 <INVENTORY> 562,930 <CURRENT-ASSETS> 26,815,850 <PP&E> 5,332,024 <DEPRECIATION> 3,382,431 <TOTAL-ASSETS> 32,838,252 <CURRENT-LIABILITIES> 2,584,802 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 115,521 <OTHER-SE> 30,137,929 <TOTAL-LIABILITY-AND-EQUITY> 32,838,252 <SALES> 6,158,270 <TOTAL-REVENUES> 6,158,270 <CGS> 3,478,428 <TOTAL-COSTS> 3,478,428 <OTHER-EXPENSES> 9,246,340 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 773 <INCOME-PRETAX> (5,466,978) <INCOME-TAX> 0 <INCOME-CONTINUING> (5,466,978) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (5,466,978) <EPS-BASIC> (.48) <EPS-DILUTED> (.48)